Market Tracker

04/28 5:16pm ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

112.35
Delayed Data
As of Apr 28
 -0.88 / -0.78%
Today’s Change
96.63
Today|||52-Week Range
177.93
+3.41%
Year-to-Date
Gilead (GILD) Q1 Earnings: Stock Likely to Beat Estimates?
Apr 25 / Zacks.com - Paid Partner Content
Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?
Apr 21 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) to Post Q1 Earnings: What's in Store?
Apr 25 / Zacks.com - Paid Partner Content
Novartis (NVS) Q1 Earnings: Will the Stock Disappoint?
Apr 20 / Zacks.com - Paid Partner Content
Celgene (CELG) to Post Q1 Earnings: What's in the Cards?
Apr 24 / Zacks.com - Paid Partner Content
Allergan (AGN) Collaborates with Novartis to Treat NASH
Apr 19 / Zacks.com - Paid Partner Content
Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again?
Apr 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close113.23
Today’s open113.00
Day’s range110.65 - 113.89
Volume214,987
Average volume (3 months)456,665
Market cap$2.8B
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-75.10%
Earnings growth (this year)+1.86%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+796.87%
P/E ratioNM
Price/Sales107.40
Price/Book8.85

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...-0.15-0.23%
----
SAGESAGE Therapeutics In...-0.72-1.00%
CLVSClovis Oncology Inc-0.32-0.55%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$4.36
Annual revenue (last year)$25.0M
Annual profit (last year)-$412.8M
Net profit margin-1,654.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Operating Officer
Jerome B. Durso
Corporate headquarters
New York, New York

Forecasts